These results led to the Epi proColon test (Epigenomics, USA), a blood‐based FDA‐approved screening test for adults with average risk for CRC, which evaluates SEPT9 methylation levels in a quantitative assay based on real‐time PCR reaction.14 Here, SEPTIN9 is linked to colorectal carcinoma.